| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/06/2003 | WO2003009779A2 Delivery of therapeutic capable agents |
| 02/06/2003 | WO2003009778A2 Methods and devices for delivery of therapeutic capable agents with variable release profile |
| 02/06/2003 | WO2003009777A2 Delivery of therapeutic capable agents |
| 02/06/2003 | WO2003009704A2 Enteral compositions for the prevention and/or treatment of sepsis |
| 02/06/2003 | WO2003009689A1 Methods and compositions for treating fungal infections |
| 02/06/2003 | WO2002093177A3 Assays for identifying modulators of rhomboid polypeptides |
| 02/06/2003 | WO2002090558A9 Novel expression vectors and uses thereof |
| 02/06/2003 | WO2002080940A3 Pharmacologically active strong acid solutions |
| 02/06/2003 | WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/06/2003 | WO2002070516A3 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 02/06/2003 | WO2002067851A3 Method for treating fibrotic diseases or other indications iiic |
| 02/06/2003 | WO2002064586A3 Heterocyclic inhibitors of erk2 and uses thereof |
| 02/06/2003 | WO2002061110A3 Nucleic acid derivatives |
| 02/06/2003 | WO2002059123A3 Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds |
| 02/06/2003 | WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors |
| 02/06/2003 | WO2002049666A3 Mycoplasma hyopneumoniae bacterin vaccine |
| 02/06/2003 | WO2002046194A3 Substituted imidazopyridines |
| 02/06/2003 | WO2002041843A3 Antiinflammation agents |
| 02/06/2003 | WO2002039953A3 Texaphyrin coordination compounds and uses thereof |
| 02/06/2003 | WO2002020722A3 Methods and compositions for in vitro targeting |
| 02/06/2003 | WO2002019963A3 Synthetic erythropoiesis stimulating proteins |
| 02/06/2003 | WO2002010137A9 Indazole derivatives as jnk inhibitors |
| 02/06/2003 | WO2002002095A3 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
| 02/06/2003 | WO2002000919A3 Screen for identifying inhibitors of glycosylphosphatidylnositol anchoring |
| 02/06/2003 | WO2002000883A3 Rescue of canine distemper virus from cdna |
| 02/06/2003 | WO2001070765A9 Receptor-binding compounds and methods for identifying them |
| 02/06/2003 | WO2001047946A3 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 02/06/2003 | US20030028028 1-oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels |
| 02/06/2003 | US20030028025 Pediatric formulation of gatifloxacin |
| 02/06/2003 | US20030028022 Preferably tertiary amines comprising tetrahydroquinoline and benzimidazole; use treating human immunodeficiency virus (HIV) and Feline Immunodeficiency Virus (FIV) |
| 02/06/2003 | US20030028008 Nucleotide sequences coding polypeptide for use in the treatment of urogenital, tumor, antherosclerotic and kidney disorders |
| 02/06/2003 | US20030028006 Cytokine receptor common gamma chain like |
| 02/06/2003 | US20030028004 68730 and 69112, protein kinase molecules and uses therefor |
| 02/06/2003 | US20030027999 143 human secreted proteins |
| 02/06/2003 | US20030027987 Novel polypeptide from Haemophilus paragallinarum and process for preparing the same |
| 02/06/2003 | US20030027867 Use of R-NSAID compounds for anti-HIV treatment |
| 02/06/2003 | US20030027852 Substituted pyrrolidine-2,3,4-trione 3-oxime deerivatives which are active as NMDA receptor antagonists |
| 02/06/2003 | US20030027851 Readily soluble crystal modification; specific X-ray diffraction pattern obtained with a focusing Debye-Scherrer beam and Cu-K alpha 1-radiation |
| 02/06/2003 | US20030027847 Carboxyformylacetamide derivatives for treatment of AIDS or ARC |
| 02/06/2003 | US20030027845 Ether derivatives useful as inhibitors of PDE4 isozymes |
| 02/06/2003 | US20030027809 1-hydroxyethyl-2(imidazo(5,1b)thiazol-2-yl-1-carbapen-2-em-3-c carboxylic acid or salt, excellent antibiotic activity against a wide spectrum of bacteria |
| 02/06/2003 | US20030027774 For diagnosis and therapy of tuberculosis |
| 02/06/2003 | US20030027299 Biochemical conjugate for use in the treatment or prevention of stroke, heart defect, veinous thrombosis, sepsis and embolism |
| 02/06/2003 | US20030027261 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 02/06/2003 | US20030027253 Nucleotides equences codin polypeptide for use in the treatment of cancer |
| 02/06/2003 | US20030027243 Screening or testing fungicide; obtain fungal protein sample, incubate with test modulator, monitor interaction between fungicide and protein, adjustment in protein activity indicate fungicide |
| 02/06/2003 | US20030027198 Nucleotide sequences coding polypeptide for use in the treatment of tumors |
| 02/06/2003 | US20030027158 Novel nucleic acid sequences encoding human breast tumor-associated protein 47-like polypeptides |
| 02/06/2003 | US20030027130 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of viral diseases |
| 02/06/2003 | US20030026814 EIAV P26 deletion vaccine and diagnostic |
| 02/06/2003 | US20030026809 Stimulantion of immunological response |
| 02/06/2003 | US20030026802 Interference with binding chemokines |
| 02/06/2003 | US20030026796 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase |
| 02/06/2003 | US20030026791 Aids therapy; insertion into cell a virus vector |
| 02/06/2003 | US20030026785 Genetic engineering; activation; administering bacteriophages; side effect reduction |
| 02/06/2003 | CA2857312A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using deoxyhypusine synthase (dhs) |
| 02/06/2003 | CA2455681A1 An inducer of apoptosis |
| 02/06/2003 | CA2455360A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 02/06/2003 | CA2454920A1 Antigenic compositions |
| 02/06/2003 | CA2454822A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using apoptosis-specific eif-5a |
| 02/06/2003 | CA2454803A1 Probiotic bifidobacterium strains |
| 02/06/2003 | CA2454734A1 New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions |
| 02/06/2003 | CA2454656A1 Methods and compositions for treating fungal infections |
| 02/06/2003 | CA2454150A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 02/06/2003 | CA2453880A1 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 02/05/2003 | WO2002014280A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 02/05/2003 | EP1282084A2 Method for preparing pyrimidone derivatives with antifungal activity |
| 02/05/2003 | EP1281962A1 Method for the screening of compounds that inhibit the interaction between a proline-rich peptide and an SH3 domain comprising peptide |
| 02/05/2003 | EP1281761A1 Hepatitis B virus pre-S1 derived synthetic polypeptides and their use thereof. |
| 02/05/2003 | EP1281754A1 Hiv-producing cell line and use thereof |
| 02/05/2003 | EP1281715A1 Process for the preparation of ribavirin |
| 02/05/2003 | EP1281401A2 The medical effect of Jojoba oil |
| 02/05/2003 | EP1281397A1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 02/05/2003 | EP1281325A1 Nutritional composition preventing bacterial overgrowth |
| 02/05/2003 | EP1280924A2 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses |
| 02/05/2003 | EP1280897A2 Regulation of nf-at interacting protein nip 45 variant |
| 02/05/2003 | EP1280828A2 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses |
| 02/05/2003 | EP1280820A2 Anti-inflammatory compounds and uses thereof |
| 02/05/2003 | EP1280815A1 29 human secreted proteins |
| 02/05/2003 | EP1280813A1 Anti-viral pyrimidine nucleoside analogues |
| 02/05/2003 | EP1280808A1 Improved beta-lactam antibiotics |
| 02/05/2003 | EP1280796A1 Pyrimidinyl methyl indole derivatives with antibacterial activity |
| 02/05/2003 | EP1280795A2 N-substituted carbamoyloxyalkyl-azolium derivatives |
| 02/05/2003 | EP1280777A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/05/2003 | EP1280551A2 Immunizing against hiv infection |
| 02/05/2003 | EP1280537A2 Compositions of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof |
| 02/05/2003 | EP1280535A1 Processes for preparing clarithromycin polymorphs |
| 02/05/2003 | EP1280518A2 Liposome drug delivery |
| 02/05/2003 | EP1280517A1 Beta-glucans encapsulated in liposomes |
| 02/05/2003 | EP1280515A2 Pharmaceutical compositions comprising cannabis |
| 02/05/2003 | EP1280500A2 Synergistic antiplaque/antigingivitis oral composition |
| 02/05/2003 | EP0909178B1 Interleukin-8 as an antiviral and antitumor agent |
| 02/05/2003 | EP0841904B1 Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors |
| 02/05/2003 | EP0841903B1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 02/05/2003 | EP0804231B1 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| 02/05/2003 | EP0794787B1 Compositions for the treatment of parasitic and fungal infections |
| 02/05/2003 | CN1395617A A humanized antibody to surface antigen S of hepatitis B virus and preparing method thereof |
| 02/05/2003 | CN1395613A 抗微生物组合物 The antimicrobial composition |
| 02/05/2003 | CN1395579A Method for synthesis of alpha-D-GA (1-3) GAL-containing oligosaccharides |
| 02/05/2003 | CN1395573A Extraction of flavonoids |